These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 19818481)
1. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy. Uberti EM; Fajardo Mdo C; Ferreira SV; Pereira MV; Seger RC; Moreira MA; Torres MD; de Nápoli G; Schmid H Gynecol Oncol; 2009 Dec; 115(3):476-81. PubMed ID: 19818481 [TBL] [Abstract][Full Text] [Related]
2. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment. Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681 [TBL] [Abstract][Full Text] [Related]
3. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole. Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471 [TBL] [Abstract][Full Text] [Related]
4. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Stone M; Bagshawe KD Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole]. Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934 [TBL] [Abstract][Full Text] [Related]
8. [The reproductive function following a hydatidiform mole]. Flici O; Tadjerouni A; Robyn C J Gynecol Obstet Biol Reprod (Paris); 1984; 13(1):67-76. PubMed ID: 6327801 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic actinomycin D for high-risk complete hydatidiform mole. Limpongsanurak S J Reprod Med; 2001 Feb; 46(2):110-6. PubMed ID: 11255809 [TBL] [Abstract][Full Text] [Related]
10. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931 [TBL] [Abstract][Full Text] [Related]
11. Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China. Zhao Y; Zhang W; Duan W J Reprod Med; 2009 Feb; 54(2):88-94. PubMed ID: 19301571 [TBL] [Abstract][Full Text] [Related]
12. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Kim JH; Park DC; Bae SN; Namkoong SE; Kim SJ Gynecol Oncol; 1998 Oct; 71(1):108-12. PubMed ID: 9784329 [TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic diseases in Turkey. Ozalp SS; Oge T J Reprod Med; 2013; 58(1-2):67-71. PubMed ID: 23447922 [TBL] [Abstract][Full Text] [Related]
14. [Gestational trophoblastic tumors and recent clinical information]. Shimizu T; Yaegashi N Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462 [TBL] [Abstract][Full Text] [Related]
15. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy. Lurain JR; Brewer JI Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of the primary hydatidiform mole. Berkowitz RS; Goldstein DP Obstet Gynecol Clin North Am; 1988 Sep; 15(3):491-503. PubMed ID: 3067171 [TBL] [Abstract][Full Text] [Related]
17. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience. Kim SJ; Na YJ; Jung SG; Kim CJ; Bae SN; Lee C J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600 [TBL] [Abstract][Full Text] [Related]
18. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Lurain JR Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069 [TBL] [Abstract][Full Text] [Related]
19. Increased gestational age at evacuation of a complete hydatidiform mole: does it correlate with increased risk of requiring chemotherapy? Seckl MJ; Dhillon T; Dancey G; Foskett M; Paradinas FJ; Rees HC; Sebire N; Vigushin DM; Newlands ES J Reprod Med; 2004 Jul; 49(7):527-30. PubMed ID: 15305823 [TBL] [Abstract][Full Text] [Related]
20. Persistent trophoblast disease following partial molar pregnancy. Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]